Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Quality of Life × apatinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Stomach Neoplasms 53 Carcinoma, Hepatocellular 39 Carcinoma, Non-Small-Cell Lung 21 Small Cell Lung Carcinoma 18 Ovarian Neoplasms 17 Colorectal Neoplasms 15 Sarcoma 13 Breast Neoplasms 13 Triple Negative Breast Neoplasms 11 Nasopharyngeal Carcinoma 11 Neoplasms 10 Esophageal Squamous Cell Carcinoma 10 Cholangiocarcinoma 10 Esophageal Neoplasms 9 Neoplasm Metastasis 7 Advanced Gastric Cancer 7 Squamous Cell Carcinoma of Head and Neck 6 Recurrence 6 Osteosarcoma 6 Lung Neoplasms 6 Head and Neck Neoplasms 6 Biliary Tract Neoplasms 6 Uterine Cervical Neoplasms 5 Solid Tumor 4 Pancreatic Neoplasms 4 Melanoma 4 Liver Neoplasms 4 Thyroid Neoplasms 3 NSCLC 3 Glioma 3

Interventions

endostar protein 1 coenzyme Q10 1 apatinib 1 Yoga 1 Ubiquinone 1 Tamoxifen 1 Referral and Consultation 1 Palliative Care 1 Oxaliplatin 1 Melatonin 1 Exercise 1 Educational Status 1 Chemoradiotherapy 1 Capecitabine 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02998242 2019-05-21

ARCAP

Sichuan Provincial People's Hospital

Phase NA Completed

Quality of Life

Data powered by HemOnc (CC BY 4.0) Colophon ⚡